Peptidepharma Nova SL announces the new Headquarter that will house its Business units based on peptide synthesis for cosmetical, veterinary and pharmaceutical applications. The new campus is now under construction and will be finished by 2023 with an high cost investment for the company.
The new headquarter is located near Barcelona in the industrial are of Gava where some other pharmaceutical and cosmetic companies are located. The modern unit, of about 2500 m2, will include Research and Development laboratories, Production areas quality certified. The new building will also house Peptidepharma administrative offices.
Peptidepharma main business will be focused to development of new biomimetic peptides, pharmaceutical peptides both for experimental, human and veterinary applications focused to cancer treatment and vaccines. Peptides for cosmetic applications will be also an important business goal.